DGKZ and acute myeloid leukemia: Apoptosis and necrosis assays confirmed that BAY 2965501 treatment induced a statistically significant increase in both apoptotic and necrotic cell death across sensitive AML cell lines, similarly to what observed with DGKζ-IN-4.